The effects of recombinant interleukin 2 (IL-2) on the in vitro differentiation of human tonsillar B cells which were not preincubated with Staphylococcus aureus Cowan I or with anti-human IgM were investigated. IL-2 was shown to induce the generation of Ig-containing cells in a dose-dependent fashion from 2.5 to 2,500 U IL-2/ml. Conversely, the quantities of Ig secreted in the culture supernatant were found in the majority of experiments to peak at 25 U/ml. The possible presence, in cultures stimulated with IL-2, of cells that were capable of synthesizing Ig but that did not secrete the Ig they have produced was investigated.
Introduction
Interleukin 2 (IL-2)' and y-interferon (-y-IFN) are among the most well-characterized lymphokines, both biochemically and with regard to their effects on various components ofthe immune response. However, their precise roles in the modulation of B cell differentiation still remain unclear. Using highly purified IL-2 produced by T cells or T cell clones stimulated either with antigen or mitogen, a number of independent studies have led to the conclusion that IL-2 can trigger murine B cell proliferation and/or differentiation, but this was due to the fact that either the IL-2 preparations contained some T cell helper factors for B cells or IL-2 was actually acting on residual T cells contaminating B cell preparations (1) (2) (3) . Those residual T cells were reported to be induced by IL-2 and antigen into either helper cells or helper factor-producing cells. Murine y-IFN has been reported to induce antigen-stimulated B cell differentiation in the presence of T cell and/or macrophage supernatants (4) (5) (6) , or to be a direct B cell-maturing lymphokine (7) .
Recent technological progress has allowed for the preparation of recombinant IL-2 and -y-IFN, both now available in large quantities. This has led to the publication ofa number ofreports which have created a new consensus: in vitro mitogen-preactivated murine (8) or human (9-11) B cells express receptors for IL-2 on their surface which allow them to proliferate in response to IL-2. However, controversial data still are being reported with regard to the in vitro differentiation of mitogen-preactivated B cells in response to IL-2. For example, IL-2 has been reported to be unable, when used alone, to induce differentiation of normal human B cells stimulated with Staphylococcus aureus Cowan I (SAC) (12) (13) (14) , or of murine B cells preactivated in vitro with anti-IgM (15) . These data are consistent with those published by Pure et al. ( 16) (17) which show that IL-2 can in fact induce human B cells preactivated by SAC to differentiate into Ig-secreting cells, and to data from Zubler et al. (8) demonstrating that IL-2 can induce murine B cells which have interacted with anti-mouse Ig during their preparation to differentiate into Ig-secreting cells provided they were exposed simultaneously to LPS and anti-IgM. In these studies, it was not reported whether IL-2 could act on freshly isolated B cells in the absence of an in vitro preactivation step delivered by the addition of mitogen.
In the present report, using human tonsillar B cell preparations containing no detectable T cells, monocytes, or natural killer cells both before and at the end ofthe cultures and recombinant IL-2 at doses ranging from 0 to 2,500 U/ml, we demonstrated that IL-2 alone, when used at appropriate concentrations, induced the in vitro differentiation of B cells which were not preactivated with either SAC or anti-IgM. added, where indicated, at the beginning of the cultures in final concentrations from 0 to 2,500 U/ml and from 0 to 25,000 U/ml, respectively. (19) . Ig-secreting cells were detected using a protein-A plaque-forming cell (PFC) assay as already detailed elsewhere (18) .
Assayfor endogenous -y-IFN production. into Ig-secreting cells. This hypothesis was further investigated using -y-IFN as a cohelper factor.
Synergy between IL-2 and y-IFN in the induction ofB cell differentiation. To determine the potential synergistic relationship between IL-2 and y-IFN in the induction of B cell differentiation, it was first necessary to determine the effects of y-IFN alone on B cell differentiation in our system. We have found that no effects of -y-IFN could be demonstrated either on the generation of Ig CC or on the secretion of Ig at any concentration tested from 0 to 25,000 U/mi. The effect(s) of y-IFN on IL-2-induced B cell differentiation was investigated in experiments where either IL-2 alone, -y-IFN alone, or both were added to cultures of B cells (Table III) . The addition of IL-2 alone resulted in an increase in the numbers of Ig CC and in the quantity of Ig secreted in the culture supernatants when compared with controls with no IL-2 added, thus confirming data reported above. The addition of y-IFN alone to cultures did not lead to 
Discussion
The present study demonstrates that in the presence of recombinant IL-2, differentiation of human B cells which were not intentionally preactivated in vitro with antigen or mitogen oc- The experiments in the present study were performed using B cell suspensions containing no detectable T cells, monocytes, or NK cells both at the initiation and at the end of cultures. Furthermore, these cells did not respond to PWM (Table I) , nor did they produce y-IFN above the background detected in con- ml, which are far higher concentrations than that ofthe contamination of IL-2 preparation used in this study, nor did they synergize with IL-2 in inducing human B cell differentiation (data not shown). Furthermore, care was taken not to activate B cells in the fractionation procedure in that they were obtained by a negative selection protocol which consisted of incubation and centrifugation on Hypaque-Ficoll gradients without obvious perturbation of surface Ig or surface antigen on B cell membranes. It is of note that most of the studies leading to the conclusions that B cells must be rechallenged in vitro with antigen or preactivated with mitogen in order to respond to IL-2 were performed with suboptimal doses of IL-2 (1-3). It is possible that IL-2 at low concentrations cannot act on cells bearing either low numbers of IL-2 receptors or low affinity receptors and that mitogen or antigen were required in order either to expand the density of IL-2 receptors or to induce receptors with sufficient avidity for low concentrations of this lymphokine. The first hypothesis is given added credence by descriptions of the marked heterogeneity of IL-2 receptor density on the surface of normal T cells (21) . In this regard, at limiting IL-2 concentrations, only T cells bearing high density receptors for IL-2 are triggered by IL-2 (21). The second possibility is supported by the existence of low affinity receptors for IL-2, which have been described on leukemic cell membranes (21) and on various human cell types (22 In addition to demonstrating that the effects of y-IFN are restricted to a precise phase of the B cell maturation process (since y-IFN did not induce Ig synthesis but only increased Ig secretion in IL-2 stimulated cultures), the present study provides experimental support for the concept that the in vitro differentiation of B cells into Ig-synthesizing cells and their further differentiation into Ig-secreting cells are distinct steps which can be individually regulated by different factors or signals. Such a concept has been repeatedly suggested (1) (2) (3) 14) , although little experimental data clearly dissecting the consecutive sequences of the later phases of B cell maturation have been reported. This observation, when coupled with the fact that no in vitro preincubation ofthe responding cells with polyclonal B cell activators such as SAC or anti-IgM was required in order for them to respond to IL-2, may be helpful in attempts to correct immune disorders with lymphokines.
